Despite the major unmet clinical need, no new medications for the treatment of AD have been approved since 2003
Glutamate has an essential role in In two Phase 3 studies for Alzheimer disease, randomized patients in a blinded treatment were genotyped with respect to the
1016/S1474-4422 (08)70261-8 Abstract Background: The
In this multicenter, international study, patients diagnosed with probable
Common side effects of galantamine may include: nausea, vomiting, diarrhea, loss of
Participants 653 patients with mild to moderate Alzheimer's disease
, Titusville, NJ, USA]) is a reversible, competitive ChEI and a positive allosteric modulator of nicotinic receptors
Introduction Alzheimer’s disease (AD) is an age-related neuro-degenerative disorder that is increasing in prevalence as the population lives longer
The symptoms of Alzheimer's disease include confusion, memory loss or other changes in behaviour
Galantamine is available under the following different brand names: Razadyne
Significant cognitive improvements over 6 months, long-term maintenance of cognition for at least 12 months
The reminyl treatment has been conducted in dosage of 16 mg/kg daily during 6 months in 30 patients (20 female, 10 male) aged from 59 to 86 years
The SMD in the changes between the donepezil and placebo groups varied [SMD = –0
, et al
It is also an allosteric modulator at nicotinic cholinergic receptor sites potentiating cholinergic nicotinic
By 7 days, 93% to 99% of the radioactivity had been recovered, with about 95% in urine and about 5% in the feces
Namenda, approved to treat moderate-to-severe AD, is given Alzheimer’s patients to help with memory, attention, reasoning, language, and the ability to perform simple tasks
Galantamine will not cure Alzheimer's disease, and it will not stop the disease from getting worse